NAVI
52
5
EXC
53
-3
BAC
53
3
YUM
47
3
LH
43
-2
A
43
2
NKE
36
6
CPB
30
6
URI
65
5
XYL
49
4
HP
48
3
KLAC
47
4
INTU
56
-4
PNC
64
4
COF
60
2
KHC
24
13
PGR
65
2
BA
54
5
NWL
53
3
EFX
38
2
NAVI
52
5
EXC
53
-3
BAC
53
3
YUM
47
3
LH
43
-2
A
43
2
NKE
36
6
CPB
30
6
URI
65
5
XYL
49
4
HP
48
3
KLAC
47
4
INTU
56
-4
PNC
64
4
COF
60
2
KHC
24
13
PGR
65
2
BA
54
5
NWL
53
3
EFX
38
2
Financhill
Back

Lumos Pharma Stock Price Chart

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30

LUMO
Lumos Pharma

Last Price:
4.31
Seasonality Move:
7.61%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.
  • The current trend is moderately bullish and LUMO is experiencing selling pressure, which indicates risk of future bearish movement.

Lumos Pharma Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 4.32 Sell
20-day SMA: 4.35 Sell
50-day SMA: 4.08 Buy
200-day SMA: 3 Buy
8-day EMA: 4.33 Sell
20-day EMA: 4.29 Buy
50-day EMA: 4.02 Buy
200-day EMA: 3.33 Buy

Lumos Pharma Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.08 Buy
Relative Strength Index (14 RSI): 54.93 Buy
Chaikin Money Flow: -113710 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.16 - 4.46) Sell
Bollinger Bands (100): (2.27 - 4.33) Buy

Lumos Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Lumos Pharma Stock

Is Lumos Pharma Stock a Buy?

  • Lumos Pharma share price is 4.31 while LUMO 8-day simple moving average is 4.32, which is a Sell signal.
  • The stock price of LUMO is 4.31 while Lumos Pharma 20-day SMA is 4.35, which makes it a Sell.
  • Lumos Pharma 50-day simple moving average is 4.08 while LUMO share price is 4.31, making it a Buy technically.
  • LUMO stock price is 4.31 and Lumos Pharma 200-day simple moving average is 3.00, creating a Buy signal.

LUMO Technical Analysis vs Fundamental Analysis

Sell
30
Lumos Pharma (LUMO) is a Sell

Is Lumos Pharma a Buy or a Sell?

  • Lumos Pharma stock is rated a Sell
    The current Lumos Pharma [LUMO] share price is $4.31. The Score for LUMO is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.

Lumos Pharma Stock Info

Market Cap:
37.28M
Price in USD:
4.31
Share Volume:
142.14K

Lumos Pharma 52-Week Range

52-Week High:
4.58
52-Week Low:
1.37
Sell
30
Lumos Pharma (LUMO) is a Sell

Lumos Pharma Share Price Forecast

  • What is the Lumos Pharma stock price today?
    The Lumos Pharma stock price is 4.31 USD today.
  • Will LUMO stock go up or go down?
    Lumos Pharma> share price is forecast to RISE/FALL based on technical indicators
  • Is Lumos Pharma overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, Lumos Pharma is overvalued.

Is Lumos Pharma Stock a Buy?

  • Lumos Pharma share price is 4.31 while LUMO 8-day exponential moving average is 4.33, which is a Sell signal.
  • The stock price of LUMO is 4.31 while Lumos Pharma 20-day EMA is 4.29, which makes it a Buy.
  • Lumos Pharma 50-day exponential moving average is 4.02 while LUMO share price is 4.31, making it a Buy technically.
  • LUMO stock price is 4.31 and Lumos Pharma 200-day simple moving average is 3.33, creating a Buy signal.

Fundamental Analysis of Lumos Pharma

Is Lumos Pharma a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.59 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $2.11 per share.

Technical Analysis of Lumos Pharma

Should I short Lumos Pharma stock?

* Lumos Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.